Gilead Hits Cipla With Patent Suit Over HIV Drug Emtriva
Gilead Sciences Inc. lodged a suit against Cipla Ltd. in New York federal court Monday, claiming the generic drugmaker infringed two patents covering its drug Emtriva, a medication used to treat...To view the full article, register now.
Already a subscriber? Click here to view full article